bcax: the income statement

MyFinsight

Bicara Therapeutics Inc. (BCAX)

For the quarter ending 2025-06-30, BCAX made $4,682K in revenue. -$27,388K in net income. Net profit margin of -584.96%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Income tax expense	52
Research and development-Related Party	2,932
Research and development-Nonrelated Party	21,866
General and administrative	7,220
Total operating expenses	32,018
Loss from operations	-32,018
Interest income	4,682
Total other income	4,682
Net loss before income taxes	-27,336
Net loss	-27,388

Net loss per share, basic (in usd per share)	-0.5
Net loss per share, diluted (in usd per share)	-0.5
Weighted-average number common shares outstanding, basic (in shares)	54,539,230
Weighted-average number common shares outstanding, diluted (in shares)	54,539,230

Unit: Thousand (K) dollars (except for numbers of shares and EPS)